ClinicalTrials.Veeva

Menu

Application of Perioperative Remote Ischemic Conditioning in Patients Undergoing Hepatectomy

C

Chongqing Medical University

Status

Completed

Conditions

Hepatic Hemangioma
Hepatectomy
Hepatolithiasis
Liver Cancer

Treatments

Device: Remote Ischemic Conditioning Once Daily
Device: Sham-Remote Ischemic Conditioning
Device: Remote Ischemic Conditioning Twice Daily

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

Our primary aim is to investigate whether perioperative remote ischemic conditioning (PRIC) as an adjunctive treatment can improve postoperative recovery in patients undergoing hepatectomy as an adjunct to standard treatment.

Full description

Remote Ischemic Conditioning (RIC) can be applied as repeated short-lasting ischemia in a distant tissue that results in protection against subsequent long-lasting ischemic injury in the target organ. This protection can be applied prior to or during a prolonged ischemic event as remote ischemic pre-conditioning (RIPreC) and per-conditioning (RIPerC), respectively, or immediate after reperfusion as remote ischemic post-conditioning (RIPostC).

RIC is a non-pharmacologic and non-invasive treatment without noticeable discomfort, commonly achieved by inflation of a blood pressure cuff to induce 5-minute cycles of limb ischemia alternating with 5 minutes of reperfusion. However, whether perioperative remote ischemic conditioning (PRIC) can improve postoperative recovery in patients undergoing hepatectomy has never been investigated in a randomized controlled trial.

Enrollment

135 patients

Sex

All

Ages

25 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients undergoing hepatectomy under general anesthesia
  • American Society of Anesthesiology (ASA) grade of II ~ III
  • Male and female patients, age 25 to 75 years
  • New York Heart Association (NYHA) grade of I ~ III

Exclusion criteria

  • Patients with limb deformity or peripheral vascular disease affecting upper limb function
  • Patients with a medical history of nervous system, immune system and mental illness
  • Patients who have received hepatectomy in the past, have important organ diseases or have undergone surgical treatment recently
  • Patients who have recently used anti-inflammatory analgesics, anticoagulants, hormone drugs, immunosuppressants, and ATP-sensitive K-channel blockers (KATP)
  • Preoperative severe renal insufficiency (serum creatinine > 442 umol/L, with or without serum potassium > 6.5 mmol/L, or the clinician-recognized need for renal replacement therapy), liver insufficiency (Child-Pugh grade C)
  • Patients and/or their family members refuse to participate in the program

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

135 participants in 3 patient groups

Sham-Remote Ischemic Conditioning
Sham Comparator group
Description:
Sham remote ischemic conditioning (Sham-RIC) is applied in the perioperative using an automated Sham-RIC device.
Treatment:
Device: Sham-Remote Ischemic Conditioning
Remote Ischemic Conditioning Once Daily
Active Comparator group
Description:
Remote ischemic conditioning (RIC) is applied in the perioperative using an automated RIC device once daily.
Treatment:
Device: Remote Ischemic Conditioning Once Daily
Remote Ischemic Conditioning Twice Daily
Active Comparator group
Description:
Remote ischemic conditioning (RIC) is applied in the perioperative using an automated RIC device twice daily.
Treatment:
Device: Remote Ischemic Conditioning Twice Daily

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems